VKTX Viking Therapeutics Inc

Viking Therapeutics Inc is a clinical-stage biopharmaceutical company. The Company develops therapies for metabolic and endocrine disorders. It includes portfolio of five drug candidates in clinical trials or preclinical studies.

$6.37  +0.26 (4.26%)
As of 06/24/2021 15:59:55 EST     IEX book   CBOE book


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  USA
Country of incorporation:  USA
IPO date:  04/29/2015
Outstanding shares:  78,100,168
Average volume:  1,191,451
Market cap:   $474,068,020
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    92686J106
ISIN:        US92686J1060
Sedol:      BQQG1V1
Valuation   (See tab for details)
PE ratio:   0.00
PB ratio:   1.56
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy